Search results for “Influenza immunization” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 124 patents, we discovered top 28 key players by total patent application. Trellis Bioscience, Inc., GlaxoSmithKline Biologicals SA, ContraFect Corp. are dominant in this area. They take 62.10% of the total patent filing.
Trellis Bioscience, Inc.
California, United States
Patent: 33
GlaxoSmithKline Biologicals SA
Belgium
Patent: 30
ContraFect Corp.
New York, United States
Patent: 14
Novartis AG
Basel-Stadt, Switzerland
Patent: 9
Apovia, Inc.
California, United States
Patent: 9
Seqirus UK Ltd.
United Kingdom
Patent: 8
Biological Mimetics, Inc.
United States
Patent: 4
The Liposome Co., Inc.
New Jersey, United States
Patent: 3
Qingdao Tianrui Technology Group Co., Ltd.
Shandong Sheng, China
Patent: 3
EpiVax, Inc.
Rhode Island, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 24 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing Shanghai Public Health Clinical Center, Trellis Bioscience, Inc., ContraFect Corp. take 58.33% of patent filing during this period.
Shanghai Public Health Clinical Center
Shanghai Shi, China
Patent: 6
Trellis Bioscience, Inc.
California, United States
Patent: 4
ContraFect Corp.
New York, United States
Patent: 4
GlaxoSmithKline Biologicals SA
Belgium
Patent: 2
St. Louis University
Missouri, United States
Patent: 2
EpiVax, Inc.
Rhode Island, United States
Patent: 2
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 2
Foshan University
Guangdong Sheng, China
Patent: 1
Beijing ABZYMO Biosciences Co. Ltd.
Beijing Shi, China
Patent: 1
Jiangsu Recbio Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 24 patents in last 5 years, we discover 8 new entrants. Shanghai Public Health Clinical Center, EpiVax, Inc., Foshan University are the most active new entrants in this area.
Shanghai Public Health Clinical Center
Shanghai Shi, China
Patent: 6
EpiVax, Inc.
Rhode Island, United States
Patent: 2
Foshan University
Guangdong Sheng, China
Patent: 1
Eurocine Vaccines AB
STOCKHOLM, Sweden
Patent: 1
Beijing ABZYMO Biosciences Co. Ltd.
Beijing Shi, China
Patent: 1
Codagenix, Inc.
New York, United States
Patent: 1
Jiangsu Recbio Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Emergent BioSolutions Canada, Inc.
Manitoba, Canada
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 45 patents, we discovered top 6 universities and scientific research institutions by total patent application. St. Louis University, Vlaams Instituut voor Biotechnologie - Flanders Institute, University of Rochester are dominant in this area. They take 62.22% of the total patent filing.
St. Louis University
Missouri, United States
Patent: 7
Vlaams Instituut voor Biotechnologie - Flanders Institute
Belgium
Patent: 5
University of Rochester
New York, United States
Patent: 1
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 1
Foshan University
Guangdong Sheng, China
Patent: 1
MCP Hahnemann University
Pennsylvania, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: